General description
Bendamustine is a antineoplastic alkylating agent, used in the treatment of chronic lymphocytic leukaemia and follicular lymphoma.
INN
Bendamustine
ATC codes
Medicine type
Chemical agent
EML status history
First added in 2015
(TRS
994)
for
Chronic lymphocytic leukaemia or small lymphocytic lymphoma
Added in 2015
(TRS
994)
for
Follicular lymphoma
Wikipedia
DrugBank
Recommendations
Section
Cytotoxic medicines
- Parenteral > General injections > unspecified: 45 mg per 0.5 mL; 180 mg per 2 mL